Disc Medicine (IRON) Cash from Operations Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 74.39% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.23% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 158.60% |
| 10 | Disc Medicine | 2.76 Bn | 2.03 Bn | - | -50.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.42% |
| Dec 31, 2025 | -57.04% |
| Sep 30, 2025 | -175.32% |
| Jun 30, 2025 | -211.30% |
| Mar 31, 2025 | -23.15% |
| Dec 31, 2024 | -54.94% |
| Sep 30, 2024 | -132.22% |
| Jun 30, 2024 | -20.98% |
| Mar 31, 2024 | 5.26% |
| Dec 31, 2023 | -84.13% |
| Sep 30, 2023 | 22.86% |
| Jun 30, 2023 | -38.39% |
| Mar 31, 2023 | -158.86% |
| Dec 31, 2022 | -149.57% |
| Sep 30, 2022 | 39.79% |
| Jun 30, 2022 | 42.28% |
| Mar 31, 2022 | 8.70% |
| Dec 31, 2021 | 4,782.39% |
| Sep 30, 2021 | -8,346.85% |
| Jun 30, 2021 | -126.48% |
| Mar 31, 2021 | -51.88% |